In the dormant TME, IL-6 signaling was constrained to stromal cells such as ECs and fibroblasts which are seen to interact among themselves while in the DTX treated tumor tissue, IL-6 activity occurs primarily between the cancer cells and the ECs, fibroblasts characterizing the emergence of complex interactions between cancer cells and stromal cells upon DTX treatment. Here, IL6 is linked to neoplasm.